All In MedTech

Company

Pulmonx

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Pulmonx is on our public-company list (ticker LUNG). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

LUNG

Nasdaq · Pulmonx Corp

Public float

$101M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$90.5M

Fiscal year ending Dec 31, 2025

Net income

-$54.0M

Fiscal year ending Dec 31, 2025

R&D spending

$19.5M

Fiscal year ending Dec 31, 2025

Cash

$52.7M

As of Sep 30, 2026

Long-term debt

$37.8M

As of Sep 30, 2026

Shares outstanding

43.6M

As of Oct 29, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2023––$20.0M–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Pulmonx we have 3 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

2 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT06035120 · 200 participants (planned) · Start Feb 22, 2024 · Primary completion Jun 30, 2027

    Device: AeriSeal System · For: Emphysema, Pulmonary; Emphysema or COPD

    Sites: Phoenix, Arizona; Loveland, Colorado; Hartford, Connecticut · 38 sites in all

  • NCT06332885 · 140 participants (planned) · Start Mar 12, 2024 · Primary completion Mar 31, 2027

    Device: Zephyr Endobronchial Valve · For: Emphysema; COPD; Severe Emphysema

    Sites: Aichi, Japan; Gifu, Japan; Kanagawa, Japan · 17 sites in all

  • Zephyr Valve Registry (ZEVR)Active, not recruiting

    NCT04186546 · 150 participants (planned) · Start Nov 25, 2019 · Primary completion Dec 31, 2026

    Device: Zephyr Valve Procedure · For: Emphysema

    Sites: Birmingham, Alabama; Chicago, Illinois; Winfield, Illinois · 11 sites in all

12 more trials with a free account

Reports received

99

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

12

12% of reports

Injury reports

74

75% of reports

Death reports

13

13% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231820
Jan 240700
Feb 240930
Mar 240230
Apr 243730
May 243020
Jun 2411700
Jul 2401100
Aug 240130
Sep 241000
Oct 241600
Nov 2411520
Dec 2402110
Jan 250200
Feb 251300
Mar 251300
Apr 250670
May 251100
Jun 250110
Jul 250010
Aug 253400
Sep 2521400
Oct 251300
Nov 250840
Dec 2511200
Jan 260000
Feb 262800
Mar 262000
Apr 262300
May 260700
Jun 2631100
Jul 262630
Aug 260100
Sep 2601130
Oct 260730
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.